![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ActiveSight, Lexicon Sign Second Protein Crystallography Service Agreement
ActiveSight, Lexicon Sign Second Protein Crystallography Service Agreement
ActiveSight announced that it has entered into a second protein crystallography services agreement with Lexicon Pharmaceuticals. The new agreement extends the co-crystallography of Lexicon's small molecule compounds to a second human drug target protein validated in-vivo by Lexicon and expressed by ActiveSight.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-27-2005/0003488859&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct